comparemela.com

Latest Breaking News On - Medication management solutions - Page 2 : comparemela.com

Pharmacy Automation Can Be a Means to Drug Safety

In the pharmacy, time is the ultimate value-add.

United statesJ clin pharmAmerican medical associationNational academiesSeverity of medication administration errorsMedication management solutionsBuildinga safer health systemJ health syst pharmAssociation of interruptions with an increased riskWorld health organizationNational coordinating council for medication errorNational coordinating councilMedication error reportingData privacy considerationsPerry flowersMedical affairs

Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript

Operator: Hello, and welcome to BD s Fourth Quarter and Full Year Fiscal 2023 Earnings Call.

United statesChris deloreficeDave hickeyErick byrdTom polenRobbie marcusPhasix hardieGreg rodetisVaginal panelEd life sciencesLife sciencesBecton dickinson coMedication management solutionsCall transcript novemberFull year fiscalSenior vice president

BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4.

United statesTroy kirkpatrickTransjugular intrahepatic portosystemicTom polenEmbecta corpRevenue growthBd life sciences revenuesBd life sciencesLife sciencesSolutions revenuesDiagnostics solutionsMedication management solutionsResearch instrumentsMedication delivery solutionsEuropean union medical device regulationCasella waste systems inc

Becton, Dickinson and Company (NYSE:BDX) Q3 2023 Earnings Call Transcript

Operator: Hello, and welcome to BD’s Third Fiscal Quarter of 2023 Earnings Call. At the request of BD, today’s call is being recorded.

United statesNew zealandChris deloreficeLarry biegelsenPatrick woodFrancesca demartinoTom polenMatt taylorDave hickeyVijay kumarRobbie marcusErick byrdMike sarconeModular track solutionsWells fargoMorgan stanley

BD Reports Third Quarter Fiscal 2023 Financial Results

Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™.

United statesTroy kirkpatrickFrancesca demartinoTom polenCompanies to workBusiness revenue growth including divestedExchange commissionBusiness organic revenue growthBd life sciences revenuesBusiness revenuesEuropean union medical device regulationRevenue growthA noteworthy company in diversityincMedication delivery solutionsBusiness revenue growth net of divestedCatheter solutions

vimarsana © 2020. All Rights Reserved.